• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成纤维细胞生长因子23在体内导致肾磷酸盐共转运体NaPi-IIa和NaPi-IIc的内溶酶体转运。

Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo.

作者信息

Küng Catharina J, Haykir Betül, Schnitzbauer Udo, Egli-Spichtig Daniela, Hernando Nati, Wagner Carsten A

机构信息

Institute of Physiology, University of Zurich and National Center of Competence in Research Kidney.CH, Zurich, Switzerland.

出版信息

Am J Physiol Renal Physiol. 2021 Dec 1;321(6):F785-F798. doi: 10.1152/ajprenal.00250.2021. Epub 2021 Nov 1.

DOI:10.1152/ajprenal.00250.2021
PMID:34719948
Abstract

Na-dependent phosphate cotransporters NaPi-IIa and NaPi-IIc, located at the brush-border membrane of renal proximal tubules, are regulated by numerous factors, including fibroblast growth factor 23 (FGF23). FGF23 downregulates NaPi-IIa and NaPi-IIc abundance after activating a signaling pathway involving phosphorylation of ERK1/2 (phospho-ERK1/2). FGF23 also downregulates expression of renal 1-α-hydroxylase () and upregulates 24-hydroxylase (), thus reducing plasma calcitriol levels. Here, we examined the time course of FGF23-induced internalization of NaPi-IIa and NaPi-IIc and their intracellular pathway toward degradation in vivo. Mice were injected intraperitoneally with recombinant human (rh)FGF23 in the absence (biochemical analysis) or presence (immunohistochemistry) of leupeptin, an inhibitor of lysosomal proteases. Phosphorylation of ERK1/2 was enhanced 60 min after rhFGF23 administration, and increased phosphorylation was still detected 480 min after injection. Colocalization of phospho-ERK1/2 with NaPi-IIa was seen at 60 and 120 min and partly at 480 min. The abundance of both cotransporters was reduced 240 min after rhFGF23 administration, with a further reduction at 480 min. NaPi-IIa and NaPi-IIc were found to colocalize with clathrin and early endosomal antigen 1 as early as 120 min after rhFGF23 injection. Both cotransporters partially colocalized with cathepsin B and lysosomal-associated membrane protein-1, markers of lysosomes, 120 min after rhFGF23 injection. Thus, NaPi-IIa and NaPi-IIc are internalized within 2 h upon rhFGF23 injection. Both cotransporters share the pathway of clathrin-mediated endocytosis that leads first to early endosomes, finally resulting in trafficking toward the lysosome as early as 120 min after rhFGF23 administration. The hormone fibroblast growth factor 23 (FGF23) controls phosphate homeostasis by regulating renal phosphate excretion. FGF23 acts on several phosphate transporters in the kidney. Here, we define the time course of this action and demonstrate how phosphate transporters NaPi-IIa and NaPi-IIc are internalized.

摘要

位于肾近端小管刷状缘膜的钠依赖性磷酸盐共转运体NaPi-IIa和NaPi-IIc受多种因素调节,包括成纤维细胞生长因子23(FGF23)。FGF23在激活涉及ERK1/2磷酸化(磷酸化ERK1/2)的信号通路后,下调NaPi-IIa和NaPi-IIc的丰度。FGF23还下调肾1-α-羟化酶()的表达并上调24-羟化酶(),从而降低血浆骨化三醇水平。在此,我们研究了FGF23诱导的NaPi-IIa和NaPi-IIc内化的时间进程及其在体内的细胞内降解途径。在不存在(生化分析)或存在(免疫组织化学)溶酶体蛋白酶抑制剂亮抑酶肽的情况下,给小鼠腹腔注射重组人(rh)FGF23。rhFGF23给药后60分钟,ERK1/2的磷酸化增强,注射后480分钟仍检测到磷酸化增加。在60分钟和120分钟时可见磷酸化ERK1/2与NaPi-IIa共定位,在480分钟时部分共定位。rhFGF23给药后240分钟,两种共转运体的丰度降低,480分钟时进一步降低。发现rhFGF23注射后120分钟,NaPi-IIa和NaPi-IIc最早与网格蛋白和早期内体抗原1共定位。rhFGF23注射后120分钟,两种共转运体均与溶酶体标记物组织蛋白酶B和溶酶体相关膜蛋白-1部分共定位。因此,rhFGF23注射后2小时内,NaPi-IIa和NaPi-IIc被内化。两种共转运体共享网格蛋白介导的内吞途径,该途径首先导致早期内体,最终在rhFGF23给药后120分钟最早导致向溶酶体的运输。激素成纤维细胞生长因子23(FGF23)通过调节肾磷酸盐排泄来控制磷酸盐稳态。FGF23作用于肾脏中的几种磷酸盐转运体。在此,我们确定了这种作用的时间进程,并证明了磷酸盐转运体NaPi-IIa和NaPi-IIc是如何被内化的。

相似文献

1
Fibroblast growth factor 23 leads to endolysosomal routing of the renal phosphate cotransporters NaPi-IIa and NaPi-IIc in vivo.成纤维细胞生长因子23在体内导致肾磷酸盐共转运体NaPi-IIa和NaPi-IIc的内溶酶体转运。
Am J Physiol Renal Physiol. 2021 Dec 1;321(6):F785-F798. doi: 10.1152/ajprenal.00250.2021. Epub 2021 Nov 1.
2
The calcium-sensing receptor has only a parathyroid hormone-dependent role in the acute response of renal phosphate transporters to phosphate intake.钙敏感受体在肾磷酸盐转运体对磷酸盐摄入的急性反应中仅具有甲状旁腺激素依赖性作用。
Am J Physiol Renal Physiol. 2024 May 1;326(5):F792-F801. doi: 10.1152/ajprenal.00009.2024. Epub 2024 Mar 28.
3
Acute parathyroid hormone differentially regulates renal brush border membrane phosphate cotransporters.急性甲状旁腺激素对肾脏刷状缘膜磷酸盐协同转运蛋白的调节作用不同。
Pflugers Arch. 2010 Aug;460(3):677-87. doi: 10.1007/s00424-010-0841-1. Epub 2010 Jun 5.
4
FGF23 decreases renal NaPi-2a and NaPi-2c expression and induces hypophosphatemia in vivo predominantly via FGF receptor 1.成纤维细胞生长因子23(FGF23)可降低肾脏中钠-磷协同转运蛋白2a(NaPi-2a)和钠-磷协同转运蛋白2c(NaPi-2c)的表达,并主要通过成纤维细胞生长因子受体1(FGF受体1)在体内诱导低磷血症。
Am J Physiol Renal Physiol. 2009 Aug;297(2):F282-91. doi: 10.1152/ajprenal.90742.2008. Epub 2009 Jun 10.
5
The renal Na+/phosphate cotransporter NaPi-IIa is internalized via the receptor-mediated endocytic route in response to parathyroid hormone.肾脏的钠/磷酸盐共转运体NaPi-IIa会响应甲状旁腺激素,通过受体介导的内吞途径被内化。
Kidney Int. 2006 Feb;69(3):495-503. doi: 10.1038/sj.ki.5000148.
6
Vitamin D and type II sodium-dependent phosphate cotransporters.维生素D与II型钠依赖性磷酸盐共转运体
Contrib Nephrol. 2013;180:86-97. doi: 10.1159/000346786. Epub 2013 May 6.
7
Renal phosphaturia during metabolic acidosis revisited: molecular mechanisms for decreased renal phosphate reabsorption.代谢性酸中毒期间的肾性磷酸盐尿症再探讨:肾磷酸盐重吸收减少的分子机制
Pflugers Arch. 2008 Nov;457(2):539-49. doi: 10.1007/s00424-008-0530-5. Epub 2008 Jun 6.
8
The phosphate transporter NaPi-IIa determines the rapid renal adaptation to dietary phosphate intake in mouse irrespective of persistently high FGF23 levels.磷酸转运蛋白 NaPi-IIa 决定了小鼠对饮食中磷酸盐摄入的快速肾脏适应,而与持续高水平的 FGF23 无关。
Pflugers Arch. 2013 Nov;465(11):1557-72. doi: 10.1007/s00424-013-1298-9. Epub 2013 May 26.
9
Acute adaptation of renal phosphate transporters in the murine kidney to oral phosphate intake requires multiple signals.急性适应肾脏磷酸盐转运蛋白需要多种信号,这些信号源于小鼠肾脏对口服磷酸盐的摄取。
Acta Physiol (Oxf). 2022 Jun;235(2):e13815. doi: 10.1111/apha.13815. Epub 2022 Apr 6.
10
Klotho/fibroblast growth factor 23- and PTH-independent estrogen receptor-α-mediated direct downregulation of NaPi-IIa by estrogen in the mouse kidney.在小鼠肾脏中,雌激素通过不依赖于α-klotho/成纤维细胞生长因子23和甲状旁腺激素的雌激素受体α直接下调Ⅱa型钠-磷协同转运蛋白。
Am J Physiol Renal Physiol. 2016 Aug 1;311(2):F249-59. doi: 10.1152/ajprenal.00542.2015. Epub 2016 May 18.

引用本文的文献

1
Unmasking Skull Base Phosphaturic Mesenchymal Tumors: A Rare and Treatable Cause of Tumor-Induced Osteomalacia.揭开颅底磷酸酶性间叶肿瘤的面纱:肿瘤诱导性骨软化症的一种罕见且可治疗的病因
Indian J Otolaryngol Head Neck Surg. 2025 Jun;77(6):2252-2259. doi: 10.1007/s12070-025-05460-1. Epub 2025 Apr 23.
2
Updates on renal phosphate transport.肾磷酸盐转运的最新进展。
Curr Opin Nephrol Hypertens. 2025 Jul 1;34(4):269-275. doi: 10.1097/MNH.0000000000001090. Epub 2025 May 13.
3
The true cost of phosphate control in chronic kidney disease.
慢性肾脏病中磷酸盐控制的真实成本。
Clin Kidney J. 2025 Mar 13;18(Suppl 1):i46-i60. doi: 10.1093/ckj/sfae434. eCollection 2025 Mar.
4
Phosphaturic mesenchymal tumor of the popliteal fossa: a case report and literature review.腘窝磷酸尿性间叶肿瘤:一例报告及文献复习
Front Oncol. 2024 Dec 19;14:1501499. doi: 10.3389/fonc.2024.1501499. eCollection 2024.
5
Controlled dietary phosphate loading in healthy young men elevates plasma phosphate and FGF23 levels.对健康年轻男性进行饮食中磷酸盐的控制性负荷会提高血浆磷酸盐和FGF23水平。
Pflugers Arch. 2025 Mar;477(3):495-508. doi: 10.1007/s00424-024-03046-4. Epub 2024 Nov 27.
6
The role of fibroblast growth factor 23 in regulation of phosphate balance.成纤维细胞生长因子 23 在调节磷平衡中的作用。
Pediatr Nephrol. 2024 Dec;39(12):3439-3451. doi: 10.1007/s00467-024-06395-5. Epub 2024 Jun 14.
7
The Ip6k1 and Ip6k2 Kinases Are Critical for Normal Renal Tubular Function.Ip6k1 和 Ip6k2 激酶对于正常的肾小管功能至关重要。
J Am Soc Nephrol. 2024 Apr 1;35(4):441-455. doi: 10.1681/ASN.0000000000000303. Epub 2024 Feb 6.
8
The use of burosumab to treat autosomal-recessive hypophosphatemic rickets type 2: rationale and a first clinical experience.布罗索尤单抗治疗2型常染色体隐性低磷性佝偻病:理论依据及首次临床经验
J Nephrol. 2024 Jun;37(5):1371-1374. doi: 10.1007/s40620-023-01884-6. Epub 2024 Feb 3.
9
Serum sclerostin is associated with recurrent kidney stone formation independent of hypercalciuria.血清硬化蛋白与复发性肾结石形成相关,独立于高钙尿症。
Clin Kidney J. 2023 Nov 1;17(1):sfad256. doi: 10.1093/ckj/sfad256. eCollection 2024 Jan.
10
The basics of phosphate metabolism.磷酸盐代谢基础。
Nephrol Dial Transplant. 2024 Jan 31;39(2):190-201. doi: 10.1093/ndt/gfad188.